ArticleFrontiers in public health2025
Reversed sex disparities in heart failure mortality in Spain, 2000-2023: a population-based analysis of older adults.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: Heart failure (HF) is a growing public health concern in Spain, ranking as the third leading cause of cardiovascular mortality and contributing substantially to hospitalizations and outpatient visits. Clinical presentation, pathophysiology, therapeutic response, and healthcare access differ significantly between sexes. This study analyzes trends in HF mortality in Spain from 2000 to 2023, with a specific focus on sex-based disparities. Methods: We conducted a population-based descriptive analysis of annual HF mortality among individuals aged 50 and older in Spain, disaggregated by sex and five-year age groups. Mortality trends were examined over two periods (2000-2008 and 2009-2023) to assess patterns of change over time. Results: Overall, HF mortality has declined in Spain, with a sharper reduction from 2000 to 2008, followed by a more gradual decrease in subsequent years. Women exhibited a 34.4% higher average HF mortality rate compared to men, although this gap narrowed significantly over the study period. Age-stratified analysis revealed higher HF mortality in men aged 50-79, while in those aged 80 and older, women exhibited higher mortality. Conclusion: Persistent sex disparities in HF mortality underscore the need for gender-sensitive approaches to cardiovascular disease prevention, diagnosis, and treatment. Public health policies must prioritize HF and integrate sex-specific considerations to address inequities and improve outcomes for both women and men.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.